The role of diagnostic imaging in the management of invasive fungal diseases - report from an interactive workshop

Mycoses

Volumn 54, Issue SUPPL. 1, 2011, Pages 27-31

  Gompelmann, D ^a   Heussel, C P ^a   Schuhmann, M ^a   Herth, F J F ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Air crescent sign; Antifungal therapy; Diagnostic imaging; Fungal diseases; Halo sign; Immunosuppression

Indexed keywords

AMPHOTERICIN B LIPID COMPLEX; CASPOFUNGIN; FLUCYTOSINE; ITRACONAZOLE; MICAFUNGIN; POSACONAZOLE; VORICONAZOLE;

ARTICLE; ASPERGILLUS FLAVUS; ASPERGILLUS FUMIGATUS; ASPERGILLUS NIGER; CANDIDIASIS; COMPUTER ASSISTED TOMOGRAPHY; CRYPTOCOCCUS NEOFORMANS; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; FUNGEMIA; IMMUNOSUPPRESSIVE TREATMENT; LUNG ASPERGILLOSIS; LUNG MYCOSIS; MENINGOENCEPHALITIS; NEUTROPHIL COUNT; PRIORITY JOURNAL; PROPHYLAXIS; PULMONARY CRYPTOCOCCOSIS; SYSTEMIC MYCOSIS; THORAX RADIOGRAPHY; ULTRASOUND; ZYGOMYCOSIS;

ANTIFUNGAL AGENTS; DIAGNOSTIC IMAGING; FUNGI; HUMANS; MYCOSES; OPPORTUNISTIC INFECTIONS;

EID: 78650076674     PISSN: 09337407     EISSN: 14390507     Source Type: Journal    
DOI: 10.1111/j.1439-0507.2010.01983.x     Document Type: Article

References (13)

1. Rüschel R. Identification of certain false-positive results in the Cand-Tec test for candidal antigen. Mycoses 1989; 32: 627-30.
2. Latge JP. Aspergillus fumigatus and aspergillosis. Clin Microbiol Rev 1999; 12: 310-50.
3. Weber C, Maas R, Steiner P et al. Wertigkeit der digitalen Thoraxaufnahme bei der Detektion von Lungeninfiltraten knochenmarkstransplantierter Patienten in der Aplasie. Fortschr Geb Röntgenstr 1999; 171: 294-301.
4. Heussel CP, Kauczor HU, Heussel G et al. Pneumonia in febrile neutropenic patients, bone-marrow and blood stem-cell recipients: use of high-resolution CT. J Clin Oncol 1997; 17: 796-805.
5. DePauw B, Walsh TJ, Donnelly JP et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 2008; 46: 1813-21.
6. Heussel CP, Ullmann AJ, Kauczor HU. Pilzpneumonie. Radiologe 2000; 40: 518-29.
7. Morrell M, Frase VJ, Kollef MH. Delaying the empiric treatment of candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortality. Antimicrob Agents Chemother 1995; 49: 3640-5.
8. Pappas PG, Kauffman CA, Andes D et al. Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis 2009; 48: 503-35.
9. Walsh TJ, Anaissie EJ, Denning DW et al. Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis 2008; 46: 327-60.
10. Perfect JR, Dismukes WE, Dromer F et al. Clinical practice guidelines for the management of cryptococcal update by the Infectious Diseases Society of America. Clin Infect Dis 2010; 50: 291-322.
11. Cornely OA, Böhme A, Buchheidt D et al. Primary prophylaxis of invasive fungal infections in patients with hematologic malignancies. Recommendations of the Infectious Diseases Working Party of the German Society for Haematology and Oncology. Haematologica 2009; 94: 113-22.
12. Calco V, Borro JM, Morales P et al. Antifungal prophylaxis during the early postoperative period of lung transplantation. Valencia Lung Transplant Group. Chest 1999; 115: 1301-4.
13. Reichenspurner H, Gamberg P, Nitschke M et al. Significant reduction in the number of fungal infections after lung-, heart-lung and heart transplantation using aerosolized amphotericin B prophylaxis. Transplant Proc 1997; 29: 627-8.